References from scientific journals

Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.

Prefontaine E, Sutherland LR, Macdonald JK, Cepoiu M. Prefontaine E, et al. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD000067. doi: 10.1002/14651858.CD000067.pub2. Cochrane Database Syst Rev. 2009. PMID: 19160175 Updated. Review.

Higher doses of azathioprine improved response. A steroid sparing effect with azathioprine was noted, with a Peto OR of 5.22 (95% CI 1.06 to 25.68) and NNT of 3 for quiescent disease. ...There is weak evidence for a steroid sparing effect with azathioprine tr …
Higher doses of azathioprine improved response. A steroid sparing effect with azathioprine was noted, with a Peto OR of 5.22 ( …

[Azathioprine].

Taéron C. Taéron C. Rev Infirm. 2009 Apr;(149):45-7. Rev Infirm. 2009. PMID: 19469139 French. No abstract available.


Azathioprine.

[No authors listed] [No authors listed] Rep Carcinog. 2004;11:III25-6. Rep Carcinog. 2004. PMID: 21089807 No abstract available.


Thiopurine toxicity.

de Wit KL, White BE, Goldsmith D. de Wit KL, et al. Br J Hosp Med (Lond). 2013 Oct;74(10):C153-6. Br J Hosp Med (Lond). 2013. PMID: 24273766 Review. No abstract available.


Azathioprine.

Huskisson EC. Huskisson EC. Clin Rheum Dis. 1984 Aug;10(2):325-32. Clin Rheum Dis. 1984. PMID: 6509884 No abstract available.


Azathioprine.

[No authors listed] [No authors listed] Br Med J. 1966 Dec 3;2(5526):1378. Br Med J. 1966. PMID: 5957425 Free PMC article. No abstract available.


Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety.

Dubinsky MC. Dubinsky MC. Clin Gastroenterol Hepatol. 2004 Sep;2(9):731-43. doi: 10.1016/s1542-3565(04)00344-1. Clin Gastroenterol Hepatol. 2004. PMID: 15354273 Review.

6-Mercaptopurine and its prodrug azathioprine remain the mainstay of immunomodulator therapy for the maintenance of a steroid-free remission in patients with IBD. Recent evidence suggests that the cytotoxic and immunosuppressive effects of azathioprine might be medi …
6-Mercaptopurine and its prodrug azathioprine remain the mainstay of immunomodulator therapy for the maintenance of a steroid-free re …

Azathioprine in dermatology.

Bardek I, Milavec-Puretić V, Lipozencić J. Bardek I, et al. Acta Dermatovenerol Croat. 2007;15(4):264-8. Acta Dermatovenerol Croat. 2007. PMID: 18093457 Review.

Azathioprine is a synthetic purine analog derived from 6-mercaptopurine. ...It is used in dermatology for treatment of immunobullous diseases, generalized eczematous disorders and photodermatoses. There is an enzyme in the metabolism of azathioprine called thiopurin …
Azathioprine is a synthetic purine analog derived from 6-mercaptopurine. ...It is used in dermatology for treatment of immunobullous …

Azathioprine: a guide for the management of dermatology patients.

Wise M, Callen JP. Wise M, et al. Dermatol Ther. 2007 Jul-Aug;20(4):206-15. doi: 10.1111/j.1529-8019.2007.00134.x. Dermatol Ther. 2007. PMID: 17970886 Review.

Azathioprine, a prodrug of 6-mercaptopurine, was developed over four decades ago. Since its development, azathioprine has been shown to have antileukemic, anti-inflammatory, and immunosuppressive properties. ...
Azathioprine, a prodrug of 6-mercaptopurine, was developed over four decades ago. Since its development, azathioprine has been …

Are we giving azathioprine too much time?

Gomollón F, García López S. Gomollón F, et al. World J Gastroenterol. 2008 Sep 28;14(36):5519-22. doi: 10.3748/wjg.14.5519. World J Gastroenterol. 2008. PMID: 18810769 Free PMC article. Review.

Azathioprine is currently the key drug in the maintenance treatment of inflammatory bowel diseases. ...Therefore, in patients with inflammatory bowel diseases in whom azathioprine is effective and well tolerated, the drug should not be stopped. ...
Azathioprine is currently the key drug in the maintenance treatment of inflammatory bowel diseases. ...Therefore, in patients with in …